Going to Altitude with a Preexisting Psychiatric Condition
Open Access
- 1 September 2019
- journal article
- research article
- Published by SAGE Publications in High Altitude Medicine & Biology
- Vol. 20 (3) , 207-214
Abstract
Psychiatric disorders have a high lifetime prevalence affecting about 30% of the global population. Not much is known about high altitude (HA) sojourns in individuals living with a psychiatric condition. This lack of scientific evidence contrasts with the anticipated increase in numbers of individuals with preexisting psychiatric conditions seeking medical advice on HA exposure. Not only are there risks associated with a HA climb, but physical activity in general is known to improve symptoms of many psychiatric disorder and enhance measures of mental well-being like quality of life and resilience. There are additional positive effects of alpine environments on mental health beyond those of physical activity. All individuals going to HA with a preexisting psychiatric condition should be in a state of stable disease with no recent change in medication. Specific considerations and recommendations apply to individual psychiatric disorders. During the HA sojourn the challenge is to separate altitude-related symptoms such as insomnia from prodromal symptoms of the underlying disorder (e.g., depressive episode) or altitude-related hyperventilation from panic attacks. In case an individual with preexisting anxiety disorder decides to go to HA there might be a predisposition toward acute mountain sickness (AMS), but it should always be considered that many symptoms of anxiety and AMS overlap. Any medication that is anticipated to be taken during ascent or at HA should be tested for compatibility with the psychiatric condition and medication before the trip.Keywords
This publication has 63 references indexed in Scilit:
- Risk factors for high-altitude headache upon acute high-altitude exposure at 3700 m in young Chinese men: a cohort studyThe Journal of Headache and Pain, 2013
- Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort studyBrain, 2012
- Oral versus Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Special Populations at Risk for Treatment Nonadherence: A Systematic ReviewSchizophrenia Research and Treatment, 2012
- Retraumatisierung – Annäherung an eine BegriffsbestimmungPPmP - Psychotherapie · Psychosomatik · Medizinische Psychologie, 2010
- Insomnia and paranoiaSchizophrenia Research, 2009
- What Happens to Intraocular Pressure at High Altitude?Investigative Ophthalmology & Visual Science, 2007
- Elevation-Dependent Symptom, Mood, and Performance Changes Produced by Exposure to Hypobaric HypoxiaThe International Journal of Aviation Psychology, 1998
- The Prodromal Phase of First-episode Psychosis: Past and Current ConceptualizationsSchizophrenia Bulletin, 1996
- Control of Anxiety and Acute Mountain Sickness in Himalayan MountaineersInternational Journal of Sports Medicine, 1992
- Changes in brain 5-hydroxytryptamine metabolism induced by hypobaric hypoxiaGeneral Pharmacology: The Vascular System, 1982